MDLN Stock Summary and Trading Ideas (Medline - Class A | NASDAQ:MDLN)

Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Medline - Class A trades on the NASDAQ stock market under the symbol MDLN.

As of March 20, 2026, MDLN stock price declined to $42.73 with 23,803,103 million shares trading.

MDLN has a beta of 2.81, meaning it tends to be more sensitive to market movements. MDLN has a correlation of 0.26 to the broad based SPY ETF.

MDLN has a market cap of $33.63 billion. This is considered a Large Cap stock.

Last quarter Medline - Class A reported $8 billion in Revenue and -$.01 earnings per share. This beat revenue expectation by $272 million and missed earnings estimates by -$.25.

The top ETF exchange traded funds that MDLN belongs to (by Net Assets): VTI, VO, VXF, VTV, FPX.

MDLN support price is $42.30 and resistance is $44.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDLN shares will trade within this expected range on the day.